We are live on
!
Find out more
Qube Research & Technologies (QRT) Portfolio holdings
AUM
$89.9B
1-Year Est. Return
20.22%
This Fund
S&P 500
This Quarter
Est. Return
-4.58%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
–
AUM
$38.3B
AUM Growth
+$10.8B
(+39%)
Cap. Flow
+$12.9B
Cap. Flow
% of AUM
33.6%
Top 10 Holdings %
Top 10 Hldgs %
9.4%
Holding
4,435
New
2,018
Increased
1,007
Reduced
916
Closed
371
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$302M |
| 2 |
Adobe
ADBE
|
+$291M |
| 3 |
Amazon
AMZN
|
+$266M |
| 4 |
Microsoft
MSFT
|
+$257M |
| 5 |
Eli Lilly
LLY
|
+$214M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$192M |
| 2 |
Chubb
CB
|
+$160M |
| 3 |
Advanced Micro Devices
AMD
|
+$144M |
| 4 |
Walt Disney
DIS
|
+$134M |
| 5 |
CVS Health
CVS
|
+$132M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.59% |
| 2 | Consumer Discretionary | 12.46% |
| 3 | Financials | 10.63% |
| 4 | Industrials | 10.62% |
| 5 | Healthcare | 10.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
Hurco Companies Inc
HURC
$137M
| $31.6K | ﹤0.01% |
+1,411
| New | +$30.7K |
|
3002
Medallion Financial
MFIN
$233M
| $31.6K | ﹤0.01% |
+4,508
| New | +$37.2K |
|
|
CTV
3003
DELISTED
Innovid Corp.
CTV
| $31.6K | ﹤0.01% |
24,708
-74,109
| -75% | -$86.7K |
|
|
SIFY
3004
Sify Technologies
SIFY
$1.06B
| $31.6K | ﹤0.01% |
+2,877
| New | +$36.9K |
|
3005
State Street SPDR US Large Cap Low Volatility Index ETF
LGLV
$1.2B
| $31.4K | ﹤0.01% |
235
+220
| +1,467% | +$30.7K |
|
3006
Inspired Entertainment
INSE
$182M
| $31.4K | ﹤0.01% |
2,622
-10,120
| -79% | -$129K |
|
3007
First Trust Nasdaq Transportation ETF
FTXR
$1.07B
| $31.3K | ﹤0.01% |
1,113
-2,039
| -65% | -$60.3K |
|
3008
First Mid Bancshares
FMBH
$1.38B
| $31.2K | ﹤0.01% |
+1,173
| New | +$32.6K |
|
|
ESPR
3009
DELISTED
Esperion Therapeutics
ESPR
| $30.9K | ﹤0.01% |
31,562
-92,419
| -75% | -$134K |
|
3010
Goldman Sachs Future Tech Leaders Equity ETF
GTEK
$222M
| $30.9K | ﹤0.01% |
+1,311
| New | +$32.8K |
|
|
CGAU
3011
Centerra Gold
CGAU
$3.58B
| $30.8K | ﹤0.01% |
+6,293
| New | +$36.8K |
|
|
NXDR
3012
Nextdoor Holdings
NXDR
$858M
| $30.8K | ﹤0.01% |
+16,901
| New | +$41.9K |
|
3013
Invesco Food & Beverage ETF
PBJ
$110M
| $30.7K | ﹤0.01% |
725
-59,265
| -99% | -$2.64M |
|
3014
Bassett Furniture
BSET
$168M
| $30.5K | ﹤0.01% |
+2,079
| New | +$32.5K |
|
3015
Boston Omaha
BOC
$425M
| $30.4K | ﹤0.01% |
1,853
-8,947
| -83% | -$160K |
|
3016
Civeo
CVEO
$350M
| $30.3K | ﹤0.01% |
+1,463
| New | +$28.4K |
|
3017
Invivyd
IVVD
$171M
| $30.3K | ﹤0.01% |
17,799
-57,731
| -76% | -$91.7K |
|
3018
Direxion Daily Semiconductor Bear 3X ETF
SOXS
$1.92B
| $30.2K | ﹤0.01% |
1
-41
| -98% | -$824K |
|
|
CELL
3019
DELISTED
PhenomeX Inc. Common Stock
CELL
| $30.2K | ﹤0.01% |
30,286
-69,432
| -70% | -$53.2K |
|
3020
BBVA Argentina
BBAR
$4.04B
| $30.2K | ﹤0.01% |
+7,277
| New | +$39K |
|
3021
Twin Disc
TWIN
$329M
| $30K | ﹤0.01% |
+2,184
| New | +$28.3K |
|
3022
The Oncology Institute
TOI
$507M
| $29.8K | ﹤0.01% |
21,301
-49,217
| -70% | -$50.9K |
|
|
CRESY
3023
Cresud
CRESY
$823M
| $29.6K | ﹤0.01% |
+4,506
| New | +$33.6K |
|
|
RDNW
3024
RideNow Group
RDNW
$248M
| $29.6K | ﹤0.01% |
4,829
-7,439
| -61% | -$60K |
|
3025
Absci
ABSI
$1.29B
| $29.5K | ﹤0.01% |
22,313
-100,006
| -82% | -$175K |
|
Similar funds
Qube Research & Technologies (QRT)'s Q3 2023 Portfolio in Review
As of Q3 2023, Qube Research & Technologies (QRT) held 4,435 positions worth $38.3B, up 39% from $27.5B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.
Qube Research & Technologies (QRT) deployed $12.9B of net new capital in Q3 2023, opening 2,018 new positions and adding to 1,007 existing holdings. Its largest new stake was Eli Lilly: 415,473 shares worth $223M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $192M trimmed.
- Qube Research & Technologies (QRT)'s largest Q3 2023 buy was Eli Lilly: 415,473 shares worth $223M.
- Qube Research & Technologies (QRT) added most to Johnson & Johnson in Q3 2023, an estimated $302M increase.
- Qube Research & Technologies (QRT)'s biggest Q3 2023 reduction was Alphabet (Google) Class C, cutting an estimated $192M.
- Qube Research & Technologies (QRT) fully exited Walt Disney in Q3 2023, selling an estimated $134M.
- Qube Research & Technologies (QRT)'s ten largest holdings make up 9.4% of its $38.3B portfolio in Q3 2023.
- Qube Research & Technologies (QRT) opened 2,018 new positions and closed 371 in Q3 2023.
- Qube Research & Technologies (QRT)'s portfolio value rose 39% quarter-over-quarter to $38.3B.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2023, filed 13 Nov 2023.